论文部分内容阅读
子宫肌瘤是卵巢甾体激素依赖性肿瘤,在子宫肌瘤组织中,已发现有雌激素受体(ER)和孕激素受体(PR),并明显高于子宫肌层组织。40岁以上的妇女患有子宫肌瘤的发生率约占30%左右。米非司酮是一种新型的抗孕激素,无雌激素、孕激素、雄激素以及抗雌激素活性。米非司酮可缩小子宫肌瘤的体积。本研究讨论米非司酮对于宫肌瘤和子
Uterine fibroids are ovarian steroid-dependent tumors that have been found to have estrogen receptor (ER) and progesterone receptors (PR) in uterine fibroids and are significantly higher than those in the myometrium. Women over the age of 40 with uterine fibroids incidence of about 30%. Mifepristone is a new type of antiprogestin with no estrogen, progestin, androgen and anti-estrogen activity. Mifepristone can reduce the size of uterine fibroids. This study discusses mifepristone for uterine fibroids and children